- Home
- VKTX vs MGNI Comparison
VKTX vs MGNI Comparison
Compare VKTX & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- MGNI
- Stock Information
- Founded
- VKTX 2012
- MGNI 2007
- Country
- VKTX United States
- MGNI United States
- Employees
- VKTX N/A
- MGNI N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- MGNI Computer Software: Programming Data Processing
- Sector
- VKTX Health Care
- MGNI Technology
- Exchange
- VKTX Nasdaq
- MGNI Nasdaq
- Market Cap
- VKTX 3.5B
- MGNI 3.1B
- IPO Year
- VKTX 2015
- MGNI N/A
- Fundamental
- Price
- VKTX $40.03
- MGNI $23.70
- Analyst Decision
- VKTX Strong Buy
- MGNI Strong Buy
- Analyst Count
- VKTX 13
- MGNI 13
- Target Price
- VKTX $86.92
- MGNI $25.31
- AVG Volume (30 Days)
- VKTX 4.6M
- MGNI 2.8M
- Earning Date
- VKTX 07-23-2025
- MGNI 08-06-2025
- Dividend Yield
- VKTX N/A
- MGNI N/A
- EPS Growth
- VKTX N/A
- MGNI N/A
- EPS
- VKTX N/A
- MGNI 0.29
- Revenue
- VKTX N/A
- MGNI $685,074,000.00
- Revenue This Year
- VKTX N/A
- MGNI $0.43
- Revenue Next Year
- VKTX $338.60
- MGNI $11.49
- P/E Ratio
- VKTX N/A
- MGNI $83.14
- Revenue Growth
- VKTX N/A
- MGNI 5.52
- 52 Week Low
- VKTX $18.92
- MGNI $8.22
- 52 Week High
- VKTX $81.73
- MGNI $25.27
- Technical
- Relative Strength Index (RSI)
- VKTX 69.97
- MGNI 59.38
- Support Level
- VKTX $39.35
- MGNI $21.78
- Resistance Level
- VKTX $41.68
- MGNI $23.18
- Average True Range (ATR)
- VKTX 2.06
- MGNI 1.08
- MACD
- VKTX 0.56
- MGNI -0.02
- Stochastic Oscillator
- VKTX 84.10
- MGNI 87.15
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About MGNI Magnite Inc.
Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.